We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The role of NPM1 alternative splicing in patients with chronic lymphocytic leukemia.
- Authors
Szelest, Monika; Masternak, Marta; Zając, Małgorzata; Chojnacki, Michał; Skórka, Katarzyna; Zaleska, Joanna; Karczmarczyk, Agnieszka; Stasiak, Grażyna; Wawrzyniak, Ewa; Kotkowska, Aleksandra; Siemieniuk-Ryś, Monika; Purkot, Joanna; Subocz, Edyta; Cichocka, Edyta; Tomczak, Waldemar; Zawirska, Daria; Giannopoulos, Krzysztof
- Abstract
Objectives: Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disease with heterogeneous clinical course. Recent studies revealed a link between NOTCH1 mutation and the overexpression of MYC and MYC-related genes involved in ribosome biogenesis and protein biosynthesis, such as nucleophosmin-1 (NPM1), in CLL cells. In the present study, we aim to evaluate the impact of the NOTCH1 mutation on the MYC and MYC induced NPM1 expression in CLL cells via quantification of their transcripts. Methods: Using qRT-PCR, we analyzed the levels of MYC and three main NPM1 splice variants in 214 samples collected from CLL patients. We assessed the impact of each splice variant on CLL prognostic markers, including the IGHV, TP53, NOTCH1, SF3B1, and MYD88 mutational status, cytogenetic aberrations, and laboratory features. Results: Significantly higher levels of NPM1.R1 transcripts in patients with unmutated compared to mutated IGHV status were found. The median time to first treatment (TTFT) in patients with a high level of NPM1.R1 was significantly shorter compared to the group with low NPM1.R1 levels (1.5 vs 33 months, p = 0.0002). Moreover, in Multivariate Cox Proportional Hazard Regression Model NPM1.R1 splice variant provided an independent prognostic value for TTFT. Conclusion: In conclusion, our study indicates the prognostic significance of the level of NPM1.R1 expression and suggests the importance of splicing alterations in the pathogenesis of CLL.
- Subjects
ALTERNATIVE RNA splicing; CHRONIC lymphocytic leukemia; RNA splicing; LYMPHOPROLIFERATIVE disorders; PROPORTIONAL hazards models; MYC oncogenes; PROTEIN synthesis
- Publication
PLoS ONE, 2022, Vol 17, Issue 10, p1
- ISSN
1932-6203
- Publication type
Article
- DOI
10.1371/journal.pone.0276674